Tuberculosis Pericarditis with Cardiac Tamponade: Management in the Resource-Limited Setting

We report a case of human immunodeficiency virus–associated pericardial tuberculosis complicated by cardiac tamponade. Emergency management and subsequent therapeutic interventions are described and then discussed with particular focus on resource-limited settings. The paucity of evidence to support clinical decisions is emphasized and the need for well designed diagnostic and therapeutic studies is highlighted.

[1]  M. Pai,et al.  Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  E. Brunetti,et al.  Short Course for Focused Assessment with Sonography for Human Immunodeficiency Virus/Tuberculosis: Preliminary Results in a Rural Setting in South Africa with High Prevalence of Human Immunodeficiency Virus and Tuberculosis , 2010, The American journal of tropical medicine and hygiene.

[3]  W. El-Sadr,et al.  Timing of initiation of antiretroviral drugs during tuberculosis therapy. , 2010, The New England journal of medicine.

[4]  M. Newell,et al.  High uptake of HIV testing for tuberculosis patients in an integrated primary health care HIV/TB programme in rural KwaZulu-Natal. , 2010, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[5]  G. Maartens,et al.  Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  C. Barros,et al.  Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis , 2009, Journal of acquired immune deficiency syndromes.

[7]  K. Sliwa,et al.  Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[8]  H. Reuter,et al.  The management of tuberculous pericardial effusion: experience in 233 consecutive patients. , 2007, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners.

[9]  H. Reuter,et al.  Diagnosing tuberculous pericarditis. , 2006, QJM : monthly journal of the Association of Physicians.

[10]  F. Tuon,et al.  Adenosine deaminase and tuberculous pericarditis--a systematic review with meta-analysis. , 2006, Acta tropica.

[11]  K. Sliwa,et al.  Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry , 2006, BMC infectious diseases.

[12]  H. Reuter,et al.  Epidemiology of pericardial effusions at a large academic hospital in South Africa , 2005, Epidemiology and Infection.

[13]  G. Cherian,et al.  Echocardiography in differentiating tuberculous from chronic idiopathic pericardial effusion , 2004, Heart.

[14]  B. Mayosi,et al.  Interventions for treating tuberculous pericarditis. , 2002, The Cochrane database of systematic reviews.

[15]  C. Wiysonge,et al.  Interventions for treating tuberculous pericarditis , 2017, The Cochrane database of systematic reviews.

[16]  S. Siziya,et al.  Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients , 2000, Heart.

[17]  J. Strang.  Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs. , 1994, The Journal of infection.

[18]  D. Girling,et al.  CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI , 1988, The Lancet.

[19]  D. Girling,et al.  CONTROLLED TRIAL OF PREDNISOLONE AS ADJUVANT IN TREATMENT OF TUBERCULOUS CONSTRICTIVE PERICARDITIS IN TRANSKEI , 1987, The Lancet.

[20]  P. Thompson,et al.  Rifampicin reduces effectiveness and bioavailability of prednisolone. , 1983, British medical journal.